Clinical Trials Logo
  1. Home
  2. CAD
  3. NCT03901079

Trial for A Novel Facilitated Antegrade Steering Technique in Revascularization of Coronary Chronic Total Occlusions

CAD Clinical Trial

Official title:
A Prospective, Multi-center, Non-Randomized Controled Trial for A Novel Facilitated Antegrade Steering Technique in Revascularization of Coronary Chronic Total Occlusions In Chinese Population--FAST CTO China

Clinical Trial Summary

To assess the safety and efficacy of the BridgePoint CTO system in recanalization of CTO lesions which are resistant to a conventional wire approach in a multicenter study in Chinese population

Clinical Trial Description

All subjects who are candidates for percutaneous coronary intervention (PCI), signed the informed consent form and had chronic total coronary occlusion (CTO) lesion will be evaluated for enrollment in this study.At least 100 subjects will be enrolled. Each site will be allowed to enroll up to a maximum of 25 subjects. Primary Effectiveness Endpoint: Technical Success: the ability of the BridgePoint Medical System to successfully facilitate placement of a guidewire beyond a CTO lesion in the true vessel lumen/within the collaterals in those cases that were otherwise refractory to treatment with a currently marketed guidewire Primary Safety Endpoint: 30-day MACE rate for CTO cases in which the BridgePoint Medical System was used. MACE is defined as the composite of cardiac death, Q-wave and non-Q-wave myocardial infarction(MI), and any ischemia-driven target lesion revascularization(TLR). ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details
NCT number NCT03901079
Study type Observational
Source Boston Scientific Corporation
Contact
Status Terminated
Phase
Start date October 8, 2018
Completion date March 24, 2021
View Details
See also
  Status Clinical Trial Phase
Terminated NCT04459299 - CorPath GRX STEMI Study
Not yet recruiting NCT02853994 - Safety and Efficacy of the DEVOIR Sirolimus-Coated Coronary Balloon in the Real-world Clinical Practice N/A
Completed NCT02440893 - Understanding the Effect of Metformin on Corus CAD (or ASGES)
Completed NCT01486030 - Effect of Exercise Stress Testing on Peripheral Gene Expression Using Corus CAD (or ASGES) Diagnostic Test
Recruiting NCT06239493 - IVUS-Guided Treatment for Percutaneous Vascular Interventions
Recruiting NCT05344612 - Comparing a Diagnostic and Treatment Strategy of Upfront CTCA With SOC in Patients With Chest Pain and Suspected CAD N/A
Completed NCT02457455 - Urgent Medical and Surgical Conditions During Flights N/A
Recruiting NCT05509010 - AI Driven National Platform for CT cOronary Angiography for clinicaL and industriaL applicatiOns Registry
Completed NCT03930589 - Remote Ischemic Conditioning in STEMI to Decrease Infarct Size N/A
Completed NCT01251302 - Utility of a Molecular Personalized Coronary Gene Expression Test (Corus CAD or ASGES) on Cardiology Practice Pattern
Withdrawn NCT02158754 - Clinician Utilization of Corus CAD (or ASGES) in Primary Care Provider Decision Making
Completed NCT01949844 - Artifact-Free High-Resolution Myocardial Perfusion MRI in Subjects With Abnormal Nuclear Myocardial Perfusion Studies N/A
Recruiting NCT04787796 - The Application of a Portable Multichannel ECG System for the Patients Suspected to Have Possible CAD or ACS N/A
Recruiting NCT03894423 - Comprehensive Computed Tomography Guidance of Coronary Bypass Graft Surgery
Completed NCT02223286 - Understanding Clinician Utilization of Corus CAD (Age/Sex/Gene Expression Score - ASGES) in Clinical Decision Making N/A
Completed NCT06154018 - Heparin Reversal With Two Different Protamine Ratios After Cardiopulmonary By-pass. N/A
Completed NCT02132611 - Coronary Orbital Atherectomy System Study N/A
Completed NCT01406990 - Aspirin Responsiveness in Women With Coronary Artery Disease N/A
Completed NCT01402804 - NSAIDs in Coronary Artery Disease Patients N/A
Completed NCT00500617 - Personalized Risk Evaluation and Diagnosis (Using Corus CAD or ASGES) in the Coronary Tree